Hospital care is the largest contributor to commercial health insurance spending growth - 42% of the increase since 2016.
Quantifying Impact of Accelerated Approval
Infographics, video, economic analyses, Faces of Accelerated Approval patient stories, opinion editorials & more.
PFCD In the States
In an effort to raise awareness of the broad impact of chronic disease across the U.S., PFCD takes a closer look at the cost of chronic disease and opportunities for change that could save lives and health care dollars.
Findings Published in Health Affairs Forefront
Precedent-setting policies to restrict access to accelerated approval drugs do not
CMS decision harms current and future treatment options for Alzheimer's and other chronic disease populations
April 8, 2022 (Washington
Sharing Rebates on Diabetes Medicines Could Save People with Diabetes $3.7 Billion a Year
A new study finds that passing along rebates and discounts directly to patients at the pharmacy counter could save individuals with diabetes $3.7 billion per year, or $791 per person if the full rebate is shared.
What does Alzheimer's Disease cost the U.S.?
Recent research data developed by IHS Markit and PFCD projects the impact of Alzheimer's disease between 2017 and 2030 in health care costs, in the value of unpaid caregiving, and also what a breakthrough treatment could mean in potential savings.
